{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:28:48Z","timestamp":1792308528072,"version":"4.4.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Historically, there has been a lack of cost-effectiveness data regarding the inclusion of universal non-invasive prenatal testing (NIPT) for trisomy 21, 18, and 13 in the benefit package of the Universal Health Coverage (UHC) in Thailand. Therefore, this study aimed to perform the cost-benefit analysis of prenatal screening tests and calculate the budget impact that would result from the implementation of a universal NIPT program. A decision-tree model was employed to evaluate cost and benefit of different prenatal chromosomal abnormalities screenings: 1) first-trimester screening (FTS), 2) NIPT, and 3) definitive diagnostic (amniocentesis). The comparison was made between these screenings and no screening in three groups of pregnant women: all ages, &lt; 35 years, and \u2265 35 years. The analysis was conducted from societal and governmental perspectives. The costs comprised direct medical, direct non-medical, and indirect costs, while the benefit was cost-avoidance associated with caring for children with trisomy and the loss of productivity for caregivers. Parameter uncertainties were evaluated through one-way and probabilistic sensitivity analyses. From a governmental perspective, all three methods were found to be cost-beneficial. Among them, FTS was identified as the most cost-beneficial, especially for pregnant women aged \u2265 35 years. From a societal perspective, the definitive diagnostic test was not cost-effective, but the other two screening tests were. The most sensitive parameters for FTS and NIPT strategies were the productivity loss of caregivers and the incidence of trisomy 21. Our study suggested that NIPT was the most cost-effective strategy in Thailand, if the cost was reduced to 47 USD. This evidence-based information can serve as a crucial resource for policymakers when making informed decisions regarding the allocation of resources for prenatal care in Thailand and similar context.<\/jats:p>","DOI":"10.1371\/journal.pone.0291622","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T17:33:32Z","timestamp":1694799212000},"page":"e0291622","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Economic evaluation of prenatal screening for fetal aneuploidies in Thailand"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4660-3961","authenticated-orcid":true,"given":"Preechaya","family":"Wongkrajang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraphun","family":"Jittikoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanvisa","family":"Udomsinprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3668-8754","authenticated-orcid":true,"given":"Pattarawalai","family":"Talungchit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sermsiri","family":"Sangroongruangsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saowalak","family":"Turongkaravee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-9823","authenticated-orcid":true,"given":"Usa","family":"Chaikledkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"2","key":"pone.0291622.ref001","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1542\/pir.2016-0198","article-title":"Trisomies","volume":"39","author":"PA Levy","year":"2018","journal-title":"Pediatr Rev"},{"key":"pone.0291622.ref002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5327\/Z2447-211520191900022","article-title":"Down syndrome in adults: success and challenge.","volume":"13","author":"M.L P Gorzoni","year":"2019","journal-title":"Geriatr Gerontol Aging."},{"key":"pone.0291622.ref003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-015-0138-y","article-title":"Down syndrome: an insight of the disease","volume":"22","author":"A Asim","year":"2015","journal-title":"J Biomed Sci"},{"issue":"7","key":"pone.0291622.ref004","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ajmg.a.61604","article-title":"Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines.","volume":"182","author":"G Capone","year":"2020","journal-title":"Part II. Am J Med Genet A"},{"issue":"4","key":"pone.0291622.ref005","first-page":"1","article-title":"Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.","volume":"19","author":"Health Quality Ontario","year":"2019","journal-title":"Ont Health Technol Assess Ser."},{"issue":"1","key":"pone.0291622.ref006","doi-asserted-by":"crossref","first-page":"101430","DOI":"10.1016\/j.rehab.2020.07.011","article-title":"The direct health care cost to Medicare of Down syndrome dementia as compared with Alzheimer\u2019s disease among 2015 Californian beneficiaries.","volume":"64","author":"E Bayen","year":"2021","journal-title":"Ann Phys Rehabil Med"},{"issue":"2","key":"pone.0291622.ref007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2008.02.046","article-title":"Health care expenditures for infants and young children with Down syndrome in a privately insured population","volume":"153","author":"SL Boulet","year":"2008","journal-title":"J Pediatr"},{"issue":"11","key":"pone.0291622.ref008","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/bdra.23295","article-title":"Hospitalizations and associated costs in a population-based study of children with Down syndrome born in Florida.","volume":"100","author":"AL Dawson","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"4","key":"pone.0291622.ref009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpeds.2011.06.007","article-title":"Direct health care costs of children and adolescents with Down syndrome","volume":"159","author":"EA Geelhoed","year":"2011","journal-title":"J Pediatr"},{"issue":"5","key":"pone.0291622.ref010","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.ridd.2011.02.024","article-title":"Cost of hospitalization and length of stay in people with Down syndrome: evidence from a national hospital discharge claims database.","volume":"32","author":"WJ Hung","year":"2011","journal-title":"Res Dev Disabil"},{"issue":"3","key":"pone.0291622.ref011","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ajmg.a.38050","article-title":"Out-of-pocket medical costs and third-party healthcare costs for children with Down syndrome","volume":"173","author":"A Kageleiry","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"1","key":"pone.0291622.ref012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-171067","article-title":"Outcomes for Hospitalized Older Adults with Down Syndrome in the United States","volume":"66","author":"P Mendiratta","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"31","key":"pone.0291622.ref013","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.3346\/jkms.2019.34.e207","article-title":"Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea.","volume":"34","author":"GW Park","year":"2019","journal-title":"J Korean Med Sci."},{"issue":"4","key":"pone.0291622.ref014","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.","volume":"136","author":"American College of Obstetricians Gynecologists Committee on Practice, Bulletins-Obstetrics Committee on, Genetics Society for Maternal-Fetal, Medicine","year":"2020","journal-title":"Obstet Gynecol."},{"issue":"9","key":"pone.0291622.ref015","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/den224","article-title":"Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A","volume":"23","author":"KO Kagan","year":"2008","journal-title":"Hum Reprod"},{"issue":"1","key":"pone.0291622.ref016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1479-828X.2010.01250.x","article-title":"Socio-demographic disparities in the uptake of prenatal screening and diagnosis in Western Australia.","volume":"51","author":"S Maxwell","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"pone.0291622.ref017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ajo.12428","article-title":"First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21.","volume":"56","author":"S Maxwell","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pone.0291622.ref018","doi-asserted-by":"crossref","first-page":"870543","DOI":"10.3389\/fpubh.2022.870543","article-title":"A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21.","volume":"10","author":"S Wang","year":"2022","journal-title":"Front Public Health."},{"issue":"2","key":"pone.0291622.ref019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000357430","article-title":"First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing.","volume":"35","author":"D Wright","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"pone.0291622.ref020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ijgo.12290","article-title":"Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand.","volume":"139","author":"P Kaewsuksai","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"pone.0291622.ref021","doi-asserted-by":"crossref","first-page":"e0251381","DOI":"10.1371\/journal.pone.0251381","article-title":"Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.","volume":"16","author":"S Pranpanus","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0291622.ref022","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1186\/s12913-019-4446-x","article-title":"Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.","volume":"19","author":"C Wanapirak","year":"2019","journal-title":"BMC Health Serv Res."},{"key":"pone.0291622.ref023","first-page":"CD011767","article-title":"Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.","volume":"11","author":"M Badeau","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0291622.ref024","unstructured":"Clinical Pathology Department Test Guide [Available from: https:\/\/www.si.mahidol.ac.th\/th\/manual\/Project\/content.html."},{"key":"pone.0291622.ref025","article-title":"Cost Benefit Analysis of Prenatal Screening Test with Thai NIPT (Thai Non- Invasive Prenatal Test) for Down Syndrome in Developing Countries.","volume":"5","author":"P Oraluck","year":"2017","journal-title":"Health Care Current Reviews."},{"issue":"1","key":"pone.0291622.ref026","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12913-019-4699-4","article-title":"Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis.","volume":"19","author":"C Wanapirak","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"pone.0291622.ref027","year":"2022","journal-title":"Free antenatal care (ANC) for pregnant women and partners"},{"key":"pone.0291622.ref028","author":"Health Intervention and Technology Assessment Program","year":"2016","journal-title":"Research Report: Assessing the Pilot Study for the Prevention of Down Syndrome"},{"key":"pone.0291622.ref029","unstructured":"Pregnancy at Age 35 Years or Older [Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/obstetric-care-consensus\/articles\/2022\/08\/pregnancy-at-age-35-years-or-older"},{"issue":"7","key":"pone.0291622.ref030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ajmg.a.32220","article-title":"The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18","volume":"146A","author":"JK Morris","year":"2008","journal-title":"Am J Med Genet A"},{"key":"pone.0291622.ref031","journal-title":"Standard cost list for health technology assessment: Health Intervention and Technology Assessment: HITAP Ministry of Public Health"},{"key":"pone.0291622.ref032","journal-title":"Thai Gross Domestic Product per capita"},{"issue":"7","key":"pone.0291622.ref033","doi-asserted-by":"crossref","first-page":"e0131402","DOI":"10.1371\/journal.pone.0131402","article-title":"A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States.","volume":"10","author":"BS Walker","year":"2015","journal-title":"PLoS One."},{"issue":"3","key":"pone.0291622.ref034","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/pd.4775","article-title":"Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies","volume":"36","author":"S Manotaya","year":"2016","journal-title":"Prenat Diagn"},{"key":"pone.0291622.ref035","first-page":"667","article-title":"Cost-benefit Analysis of Prenatal Screening and Diagnosis for Down Syndrome in Thailand","volume":"21","author":"J Pattanaphesaj","year":"2012","journal-title":"Journal of Health Science"},{"issue":"2","key":"pone.0291622.ref036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.repc.2020.05.019","article-title":"Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal.","volume":"40","author":"N Marques","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)."},{"key":"pone.0291622.ref037","year":"2021"},{"key":"pone.0291622.ref038","unstructured":"GDP growth (annual %)\u2014Thailand. [Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.MKTP.KD.ZG?locations=TH"},{"issue":"2","key":"pone.0291622.ref039","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1542\/pir.2016-0198","article-title":"Trisomies.","volume":"39","author":"PA Levy","year":"2018","journal-title":"Pediatr Rev"},{"key":"pone.0291622.ref040","author":"Office of the National Economic and Social Development Council","year":"2020","journal-title":"Birth rate 1993\u20132019"},{"key":"pone.0291622.ref041","first-page":"3","article-title":"First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free b-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome Ind J Clin Biochem)","volume":"28","author":"S. AM Shiefa","year":"2013"},{"key":"pone.0291622.ref042","first-page":"50","volume-title":"Pregnancy and Its Disorders.","author":"R.D. B Nerenz","year":"2022","edition":"7"},{"issue":"4","key":"pone.0291622.ref043","doi-asserted-by":"crossref","first-page":"e0266718","DOI":"10.1371\/journal.pone.0266718","article-title":"Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.","volume":"17","author":"G Xiao","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"pone.0291622.ref044","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000491750","article-title":"Clinical and Economic Impact of Adopting Noninvasive Prenatal Testing as a Primary Screening Method for Fetal Aneuploidies in the General Pregnancy Population.","volume":"45","author":"E Kostenko","year":"2019","journal-title":"Fetal Diagn Ther."},{"issue":"7","key":"pone.0291622.ref045","doi-asserted-by":"crossref","first-page":"e046582","DOI":"10.1136\/bmjopen-2020-046582","article-title":"Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis","volume":"11","author":"W Shang","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0291622.ref046","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/uog.14693","article-title":"Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies","volume":"45","author":"MI Evans","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"pone.0291622.ref047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","article-title":"The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.","volume":"182","author":"L Beulen","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"pone.0291622.ref048","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-genom-083118-015053","article-title":"The Emergence and Global Spread of Noninvasive Prenatal Testing.","volume":"22","author":"V Ravitsky","year":"2021","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"6","key":"pone.0291622.ref049","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/aogs.13841","article-title":"Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation.","volume":"99","author":"K Gadsboll","year":"2020","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"19","key":"pone.0291622.ref050","article-title":"The Knowledge, Attitude, Practices, and Satisfaction of Non-Invasive Prenatal Testing among Chinese Pregnant Women under Different Payment Schemes: A Comparative Study.","volume":"17","author":"W Zhu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"pone.0291622.ref051","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12884-022-05110-2","article-title":"Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.","volume":"22","author":"SA Kristalijn","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"pone.0291622.ref052","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands","volume":"105","author":"KRM van der Meij","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"11","key":"pone.0291622.ref053","doi-asserted-by":"crossref","first-page":"e005922","DOI":"10.1136\/bmjopen-2014-005922","article-title":"Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis","volume":"4","author":"M Neyt","year":"2014","journal-title":"BMJ Open"},{"issue":"8","key":"pone.0291622.ref054","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jog.14268","article-title":"Update on noninvasive prenatal testing: A review based on current worldwide research","volume":"46","author":"O. Samura","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"pone.0291622.ref055","first-page":"231","article-title":"Understanding Taiwanese Women\u2019s Decisional Experiences Regarding Prenatal Screening Procedures And Diagnostics: A Phenomenological Study.","volume":"14","author":"MM Chen","year":"2020","journal-title":"Asian Nurs Res (Korean Soc Nurs Sci)."},{"issue":"1","key":"pone.0291622.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11622\/smedj.2015001","article-title":"Combined first trimester screen or noninvasive prenatal testing or both.","volume":"56","author":"TY Tan","year":"2015","journal-title":"Singapore Med J"},{"key":"pone.0291622.ref057","article-title":"Birth rate 2018","author":"Office of the National Economic and Social Development Council.","year":"2018"},{"issue":"1","key":"pone.0291622.ref058","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12884-020-03279-y","article-title":"Prenatal screening in the era of non-invasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice.","volume":"20","author":"L Yang","year":"2020","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0291622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T17:34:06Z","timestamp":1694799246000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0291622"}},"subtitle":[],"editor":[{"given":"Burak","family":"Bayraktar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0291622","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}